Klobuchar Michael A 4
4 · Eikon Therapeutics, Inc. · Filed Mar 4, 2026
Insider Transaction Report
Form 4
Klobuchar Michael A
Chief Operating Officer
Transactions
- Award
Stock Option (Right to Buy)
[F1]2026-03-02+87,157→ 87,157 totalExercise: $14.88Exp: 2036-03-01→ Common Stock (87,157 underlying)
Footnotes (1)
- [F1]1/48th of the shares underlying the option will vest on each monthly anniversary of the vesting start date for 48 months, subject to the Reporting Person's continued service through each date.
Signature
/s/ Benjamin Thorner, Attorney-in-Fact|2026-03-04